COG Nordics 2026
Advance your biotech study with integrated CDMO and CRO expertise
Our integrated CDMO and CRO solutions—including end-to-end clinical supply services—are designed to support your program from early development through clinical execution.
March 24–25, 2026 | Malmö, Sweden | Booth #15
About COG Nordics 2026
The third annual COG Nordics conference will bring together biopharmaceutical industry leaders from Denmark, Sweden, Finland, Iceland, and Norway to explore cutting-edge developments in clinical trials, drug development, and patient-centric research.
Visit Thermo Fisher Scientific at booth #15 to learn how our integrated CDMO and CRO solutions—including end-to-end clinical supply services—can advance your biotech study. Together, we can help influence healthcare innovation across Northern Europe.
Event details
Date: March 24-25, 2026
Format: In-person
Location: Scandic Triangeln, Malmö, Sweden
Booth number: #15
Event website: COG Nordics | PBC Group
Why Thermo Fisher Scientific?
With 35 years of experience supporting sponsors conducting clinical trials—and a global network of 30+ purpose-built, connected cGMP facilities—we offer the capacity, stability, and expertise to drive efficiencies and mitigate risk at every stage of your study.
Our end-to-end clinical trial capabilities include:
- Clinical supply optimization
- Ancillary supply management
- Comparator and co-medication sourcing
- Global clinical packaging and labeling
- Label translation and design
- Storage and global logistics
- Cold chain management
- Decentralized trial support
Our integrated CDMO and CRO model enables us to support small biotechs across all modalities. Whether you’re developing a small molecule, a large molecule, or an advanced therapy, we provide the coordination, flexibility, and partnership needed to achieve success.
Attend our expert-led session
“Confidence in clinical supply: Keeping trials on track”
- Date: Tuesday, March 24
- Time: 10:20 a.m. CET
- Expert: Alina Cojocaru, Sr. Account Manager, Pharma Services, Thermo Fisher
Drug development is advancing in a period shaped by regulatory change, geopolitical pressure, and increasing operational complexity. For biotechnology organizations running global and adaptive research studies, maintaining clinical trial supply continuity has become essential to sustaining momentum and reducing risk.
In this session, we’ll examine how confidence in clinical supply is built through readiness, scale, and operational foresight. Drawing on real-world experience across regions and modalities, we’ll explore how stable infrastructure and adaptable execution help keep trials moving with greater predictability as conditions evolve.
Key takeaways will include:
- How end-to-end clinical supply control and a globally distributed network support continuity across complex trial designs and geographies
- Practical approaches to managing trade, tariff, and compliance risk through proactive planning and regional operating models
- How applied AI and automation in clinical supply operations are improving quality, efficiency, and reliability while maintaining regulatory control
Wherever you are, we are.
Visit booth #15 to explore our comprehensive capabilities for clinical trials of any size or scope.
Alternatively, schedule a 1:1 meeting with our team for an in-depth discussion about our services.
We look forward to seeing you in Sweden.
Stay connected to new discoveries, innovations, and expert scientific opinions.
Follow us on social media for the latest up-to-date event happenings.
We look forward to seeing you soon